Related Experiment Video
Updated: Jun 2, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Non-oxime pyrazole based inhibitors of B-Raf kinase
Bradley J Newhouse1, Joshua D Hansen, Jonas Grina
1Array BioPharma, 3200 Walnut Street, Boulder, CO 80301, United States. bnewhouse@arraybiopharma.com
Abstract:
The synthesis and biological evaluation of non-oxime pyrazole based B-Raf inhibitors is reported. Several oxime replacements have been prepared and have shown excellent enzyme activity. Further optimization of fused pyrazole 2a led to compound 38, a selective and potent B-Raf inhibitor.
Related Concept Videos
MAPK Signaling Cascades
Inhibition of Cdk Activity
Inhibition of CDK Activity
Antiviral Nucleoside Inhibitors
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Inhibitors of Viral Protein Synthesis

